Outcomes of patients with ER+/HER2+non-metastatic breast cancer treated with trastuzumab without chemotherapy

被引：0
|
作者：
Nguy, Susanna [1 ]
Wu, S. Peter [1 ]
Oh, Cheongeun [1 ]
Gerber, Naamit K. [1 ]
机构：
[1] NYU Langone Med Ctr, New York, NY USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-18-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-18-02
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients
    Shuai Li
    Jiayi Wu
    Ou Huang
    Jianrong He
    Li Zhu
    Weiguo Chen
    Yafen Li
    Xiaosong Chen
    Kunwei Shen
    BMC Cancer, 21
  • [2] Improved clinical outcomes associated with statin use during adjuvant chemotherapy in patients with HER2+non-metastatic breast cancer
    Zeichner, S. B.
    Shah, N. N.
    Montero, A. J.
    Gluck, S.
    Ahn, E.
    CANCER RESEARCH, 2013, 73
  • [3] Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy
    Nguy, Susanna
    Wu, S. Peter
    Oh, Cheongeun
    Gerber, Naamit K.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (03) : 815 - 830
  • [4] Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy
    Susanna Nguy
    S. Peter Wu
    Cheongeun Oh
    Naamit K. Gerber
    Breast Cancer Research and Treatment, 2021, 187 : 815 - 830
  • [5] Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+non-metastatic breast cancer
    Zeichner, S. B.
    Shah, N. N.
    Montero, A. J.
    Markward, N. J.
    Gluck, S.
    Silva, O.
    Ahn, E. R.
    CANCER RESEARCH, 2013, 73
  • [6] Targeted therapies for ER+/HER2-metastatic breast cancer
    Yamamoto-Ibusuki, Mutsuko
    Arnedos, Monica
    Andre, Fabrice
    BMC MEDICINE, 2015, 13
  • [7] Targeted therapies for ER+/HER2- metastatic breast cancer
    Mutsuko Yamamoto-Ibusuki
    Monica Arnedos
    Fabrice André
    BMC Medicine, 13
  • [8] Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy
    Nunes, Raquel A.
    Li, Xiaochun
    Kang, Soonmo Peter
    Burstein, Harold
    Roberts, Lisa
    Carney, Walter
    Blackwell, Kimberly
    Ryan, Paula
    Borges, Virginia
    Iglehart, J. Dirk
    Friedman, Paula
    Harris, Lyndsay N.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (01): : 1 - 10
  • [9] Genomic characterization and oncology outcomes of a locally advanced ER+/HER2-breast cancer cohort treated with neoadjuvant chemotherapy
    Abreu, Maira
    Furlan, Larissa
    Ma, Yutong
    Chen, Hanlin
    Ferreira, Carla
    Fares, Aline
    Constantino, Eduardo
    Nora, Gustavo R.
    Lucio, Gabriela
    Colombo, Tatiana
    Liu, Rui
    Wu, Xue
    Ou, Qiuxiang
    Araujo, Daniel V.
    CANCER RESEARCH, 2023, 83 (05)
  • [10] Response of persistent metastatic ER+/Her2-breast cancer treated with fulvestrant plus enzalutamide
    Richer, Jennifer
    Spoelstra, Nicole
    Winchester, Alyse
    Wulfkuhlue, Julia
    Gallagher, Rosa
    Sams, Sharon
    Vidal, Gregory
    Kabos, Peter
    Diamond, Jennifer
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadded, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Petricoin, Emanuel
    Elias, Anthony
    CANCER RESEARCH, 2022, 82 (04)
12345